Possible role(s) of neurokinins in CNS development and neurodegenerative or other disorders

被引:42
作者
Raffa, RB [1 ]
机构
[1] Temple Univ, Sch Pharm, Philadelphia, PA 19140 USA
关键词
substance P; neurokinins; neuroprotection; neurodegenerative disorders;
D O I
10.1016/S0149-7634(97)00070-5
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The present review is an attempt to summarize the diverse literature that suggests a role for neurokinins in a variety of CNS developmental or disease processes. The role of neurokinins in (anti)nociception is well known and is the subject of other comprehensive reviews. The focus of this review is on associations that implicate substance P or other neurokinins in certain aspects of CNS development and in various neuropathologic disorders that have neurodegenerative, psychiatric or other clinical manifestations. Also included are associations related to the central control of some ''peripheral'' functions. The amount and degree of evidence for neurokinin involvement in each situation vary from strong to speculative-critical analyses and commentaries on individual methodologies and studies are available from other sources. When viewed in this broad context, the information suggests intrinsic neuroprotective or neurodegenerative properties of neurokinins. It is proposed that these properties delineate a specialized area within the broader field of neurokinin research. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:789 / 813
页数:25
相关论文
共 307 条
[1]   FORMOTEROL AND SALBUTAMOL INHIBIT BRADYKININ-INDUCED AND HISTAMINE-INDUCED AIRWAY MICROVASCULAR LEAKAGE IN GUINEA-PIG [J].
ADVENIER, C ;
QIAN, Y ;
KOUNE, JDL ;
MOLIMARD, M ;
CANDENAS, ML ;
NALINE, E .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :792-798
[2]   RELATIVE POTENCIES OF NEUROKININS IN GUINEA-PIG TRACHEA AND HUMAN BRONCHUS [J].
ADVENIER, C ;
NALINE, E ;
DRAPEAU, G ;
REGOLI, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (02) :133-137
[3]   NEUROPEPTIDES AND DOPAMINE IN THE MARMOSET - EFFECT OF TREATMENT WITH 1-METHYL-4-PHENYL-1, 2, 3, 6 TETRAHYDROPYRIDINE (MPTP) - AN ANIMAL-MODEL FOR PARKINSONS-DISEASE [J].
ALLEN, JM ;
CROSS, AJ ;
YEATS, JC ;
GHATEI, MA ;
MCGREGOR, GP ;
CLOSE, SP ;
PAY, S ;
MARRIOTT, AS ;
TYERS, MB ;
CROW, TJ ;
BLOOM, SR .
BRAIN, 1986, 109 :143-157
[4]   SUBSTANCE-P IN CSF OF PATIENTS WITH CHRONIC PAIN SYNDROMES [J].
ALMAY, BGL ;
JOHANSSON, F ;
VONKNORRING, L ;
LEGREVES, P ;
TERENIUS, L .
PAIN, 1988, 33 (01) :3-9
[5]  
[Anonymous], J PHYSL
[6]  
AREFOLOV V A, 1989, Byulleten' Eksperimental'noi Biologii i Meditsiny, V107, P201
[7]   SUBSTANCE-P IMMUNOREACTIVITY WITHIN NEURITIC PLAQUES [J].
ARMSTRONG, DM ;
TERRY, RD .
NEUROSCIENCE LETTERS, 1985, 58 (01) :139-144
[8]   SUBSTANCE-P AND SOMATOSTATIN COEXIST WITHIN NEURITIC PLAQUES - IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMERS-DISEASE [J].
ARMSTRONG, DM ;
BENZING, WC ;
EVANS, J ;
TERRY, RD ;
SHIELDS, D ;
HANSEN, LA .
NEUROSCIENCE, 1989, 31 (03) :663-671
[9]   SOMATOSTATIN IS INCREASED IN THE BASAL GANGLIA IN HUNTINGTON DISEASE [J].
ARONIN, N ;
COOPER, PE ;
LORENZ, LJ ;
BIRD, ED ;
SAGAR, SM ;
LEEMAN, SE ;
MARTIN, JB .
ANNALS OF NEUROLOGY, 1983, 13 (05) :519-526
[10]   ALTERATIONS OF SOMATOSTATIN AND ITS MODULATION BY LEVODOPA IN MPTP-TREATED MOUSE-BRAIN [J].
ASANUMA, M ;
OGAWA, N ;
SORA, YH ;
PONGDHANA, K ;
HABA, K ;
MORI, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 100 (1-2) :155-160